[go: up one dir, main page]

IL155094A0 - Selective dopamine d4 receptor agonists for treating sexual dysfunction - Google Patents

Selective dopamine d4 receptor agonists for treating sexual dysfunction

Info

Publication number
IL155094A0
IL155094A0 IL15509401A IL15509401A IL155094A0 IL 155094 A0 IL155094 A0 IL 155094A0 IL 15509401 A IL15509401 A IL 15509401A IL 15509401 A IL15509401 A IL 15509401A IL 155094 A0 IL155094 A0 IL 155094A0
Authority
IL
Israel
Prior art keywords
receptor agonists
sexual dysfunction
treating sexual
selective dopamine
dopamine
Prior art date
Application number
IL15509401A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155094(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL155094A0 publication Critical patent/IL155094A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15509401A 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction IL155094A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction
PCT/US2001/043139 WO2002041894A2 (en) 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
IL155094A0 true IL155094A0 (en) 2003-10-31

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15509401A IL155094A0 (en) 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Country Status (24)

Country Link
EP (1) EP1345608B1 (es)
JP (1) JP2004534725A (es)
KR (1) KR20030051857A (es)
CN (1) CN1531434A (es)
AR (1) AR035600A1 (es)
AT (1) ATE358483T1 (es)
AU (2) AU2689502A (es)
BG (1) BG107810A (es)
BR (1) BR0110450A (es)
CA (1) CA2429383A1 (es)
CZ (1) CZ20031458A3 (es)
DE (1) DE60127712T2 (es)
ES (1) ES2284727T3 (es)
HU (1) HUP0402358A3 (es)
IL (1) IL155094A0 (es)
MX (1) MXPA03004547A (es)
NO (1) NO20032304L (es)
NZ (1) NZ525086A (es)
PE (1) PE20020557A1 (es)
PL (1) PL365890A1 (es)
SK (1) SK7242003A3 (es)
TW (1) TWI293254B (es)
UY (1) UY27031A1 (es)
WO (1) WO2002041894A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
JP2005531571A (ja) * 2002-05-23 2005-10-20 アボット・ラボラトリーズ 性機能不全の治療に有用なアセトアミド類およびベンズアミド類
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
CA2660476C (en) 2006-08-14 2015-11-17 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
KR20090045945A (ko) 2006-08-25 2009-05-08 베링거 인겔하임 인터내셔날 게엠베하 제어 방출 시스템 및 이의 제조방법
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
US9353067B2 (en) * 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE242220T1 (de) * 1994-08-05 2003-06-15 Pfizer Benzimidazolderivate mit dopaminerger wirkung
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
UY27031A1 (es) 2002-07-31
HUP0402358A3 (en) 2009-08-28
HUP0402358A2 (hu) 2005-03-29
AU2002226895B2 (en) 2006-10-12
BG107810A (bg) 2004-02-27
JP2004534725A (ja) 2004-11-18
KR20030051857A (ko) 2003-06-25
CA2429383A1 (en) 2002-05-30
BR0110450A (pt) 2005-02-09
SK7242003A3 (en) 2004-01-08
CN1531434A (zh) 2004-09-22
EP1345608B1 (en) 2007-04-04
HK1059884A1 (en) 2004-07-23
ES2284727T3 (es) 2007-11-16
TWI293254B (en) 2008-02-11
NZ525086A (en) 2006-07-28
WO2002041894A2 (en) 2002-05-30
AU2689502A (en) 2002-06-03
DE60127712T2 (de) 2007-12-27
MXPA03004547A (es) 2004-03-26
EP1345608A2 (en) 2003-09-24
ATE358483T1 (de) 2007-04-15
NO20032304L (no) 2003-07-15
CZ20031458A3 (cs) 2004-02-18
PE20020557A1 (es) 2002-06-25
NO20032304D0 (no) 2003-05-21
DE60127712D1 (de) 2007-05-16
AR035600A1 (es) 2004-06-16
PL365890A1 (en) 2005-01-10
WO2002041894A3 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
IL155368A0 (en) Ep4 receptor selective agonists in the treatment of osteoporosis
ZA200007694B (en) EP4 receptor selective agonists in the treatment of osteoporosis.
HUP0201184A3 (en) Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
EP1789433A4 (en) METHOD FOR THE TREATMENT OF SKIN INJURY USING SELF-ACTIVE AGONISTS OF THE ALPHA-2 ADRENEER RECEPTOR
ZA200501308B (en) Agonism of the 5HT2a receptor for treatment of thermoregulatory dysfunction
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
HUP0202687A3 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
IL154343A0 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
IL155094A0 (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
EP1332810A4 (en) ROLLING DEVICE FOR RINGS
EP1254951A4 (en) MOLECULE TRANSFERRING DEVICE, SUPPLEMENT FOR MOLECULAR TRANSFERRING DEVICE AND MOLECULE TRANSFERRING PROCESS
PL370842A1 (en) Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction
AP2005003325A0 (en) Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
IL154215A0 (en) Medicine for fighting against sexual dysfunction
AU2000275972A1 (en) Pde iii inhibitors for treating sexual dysfunction
TW435085U (en) Improved device for tranquilizing pigs
TW472525U (en) Device for removing testicles from rooster
PL338162A1 (en) Apparatus for obtaining activated water
MY155220A (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
TW474176U (en) Device for massaging perineum
SI1307192T1 (sl) Kandesartan za zdravljenje migrene
GB0115161D0 (en) Selective glucocorticoid receptor agonists
PL110623U1 (en) Pipe cutting-off apparatus
EP1562880A4 (en) PROCESS FOR THE SELECTIVE HYDROGENATION OF ALKYNES
GB9813291D0 (en) Sexual dysfunction